PEAK PHARMACEUTICALS, INC. company info

CIK 1452804
IRS Number 261973257
State of incorporation NV
Business address 14201 N. HAYDEN ROAD, SUITE A-1
None
SCOTTSDALE
AZ
85260
Mail address 14201 N. HAYDEN ROAD, SUITE A-1
None
SCOTTSDALE
AZ
85260

Short summary

PEAK PHARMACEUTICALS, INC. is a Arizona company, with head office located at 14201 N. Hayden Road, Suite A-1 Scottsdale, Arizona 85260. In 2017 the company owned a total of 4.44 thousand USD worth of assets, including 2.99 thousand USD worth of current assets. 2013 was the year when the company amassed the most assets.

PEAK PHARMACEUTICALS, INC. Income Statement

Name [in Millions USD]20072008200920102011201220132014201520162017Trends
Selling, General and Administrative Expense 0.020.02
Research and development 0.030.01
Operating Expenses 0.020.020.013.092.34-1.090.04
Operating Income (Loss) -2.341.09-0.04
Interest expense -0.700.000.00
Income Tax Expense (Benefit) 00
Net income -0.02-0.02-0.02-0.02-0.01-3.76-2.311.16-0.05

PEAK PHARMACEUTICALS, INC. Balance Sheet

Name [in Millions USD]20072008200920102011201220132014201520162017Trends
Cash and cash equivalents 0.020.010.010.010.560.450
Inventories 0.10
Intangible Assets, Net (Excluding Goodwill) 0.030.020.040.040.04
Total assets 0.010.010.010.610.410.000.010.00
Current assets 0.010.580.370.000.010.00
Accounts payable 0.080.16
Total current liabilities 0.040.380.330.140.180.20
Total liabilities 0.060.030.050.380.330.140.180.21
Common Stock, Value, Issued 0.000.000.020.010.010.010.010.01
Retained Earnings (Accumulated Deficit) -0.102.59-5.75-5.00-5.03-5.07

PEAK PHARMACEUTICALS, INC. Cash Flow

Name [in Millions USD]20072008200920102011201220132014201520162017Trends
Net income -0.02-0.02-0.02-0.02-0.01-3.76-2.311.16-0.05
Depreciation and amortization 0.010.02
Depreciation 0.000.00
Amortization of Intangible Assets 0.000.010.020
Depreciation and amortization 0.02
Deferred Income Tax Expense (Benefit) -0.01-0.00-0.38-0.17
Accounts payable 0.00-0.01
Net Cash Provided by (Used in) Operating Activities -0.02-0.01-0.02-0.02-0.93-0.25-0.20-0.02
Payments to Acquire Property, Plant, and Equipment 0.000
Net Cash Provided by (Used in) Investing Activities -0.04-0.000
Proceeds from Issuance of Common Stock 0.030
Net Cash Provided by (Used in) Financing Activities 0.0300.020.021.420.02
Cash and Cash Equivalents, Period Increase (Decrease) 0.01-0.010.00-0.00